Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.008
+0.078 (1.99%)
Nov 6, 2024, 3:43 PM EST - Market open
Pyxis Oncology Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pyxis Oncology stock have an average target of 9.00, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 124.53% from the current stock price of 4.01.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 19, 2024.
Analyst Ratings
The average analyst rating for Pyxis Oncology stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +74.63% | Sep 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +74.63% | Aug 16, 2024 |
Stifel | Stifel | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +149.48% | Aug 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +74.63% | May 16, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +149.48% | May 7, 2024 |
Financial Forecast
Revenue This Year
13.68M
Revenue Next Year
n/a
from 13.68M
EPS This Year
-1.04
from -1.85
EPS Next Year
-1.21
from -1.04
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.0M | n/a | 26.3M | ||
Avg | 13.7M | n/a | 4.3M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.92 | -1.03 | -1.02 | ||
Avg | -1.04 | -1.21 | -1.29 | ||
Low | -1.26 | -1.32 | -1.83 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.